Sotac Pharmaceuticals Ltd. Hits Upper Circuit on NSE, 28 October 2026

An exchange band is set as a percentage of the previous close and applied afresh to every session, which is why the Sotac Pharmaceuticals upper circuit reads as a one-day limit and not a lasting level. On 28 October 2026 Sotac Pharmaceuticals Ltd. reached Rs 101.3 on NSE, up 4.97% from the previous close of Rs 96.5, and the price was stopped there by the band.

At the time of writing the quote still sat on the ceiling, and by market cap the company is valued at Rs 106.63 crore.

Key Takeaways

• Sotac Pharmaceuticals Ltd. (SOTAC) hit the upper circuit on NSE at Rs 101.3 on 28 October 2026.
• The session move was +4.97% against a previous close of Rs 96.5.
• Market capitalisation stood at Rs 106.63 crore with a PE ratio of 18.49.
• No official company announcement or verified catalyst was confirmed at the time of writing.
• A price band is an exchange trading rule, not a view on the company or a recommendation.

Key Market Data

Metric	Value
Stock	Sotac Pharmaceuticals Ltd.
Current Price / LTP	Rs 101.3
Day Move	4.97%
Previous Close	Rs 96.5
Day Open	Rs 101.25
Day High	Rs 101.3
Day Low	Rs 101.25
Upper Circuit Price	Rs 101.3
Upper Circuit Limit	Rs 101.3
Market Cap	Rs 106.63 crore
Selected Exchange	NSE
PE Ratio	18.49

All figures above are as of 28 October 2026, sourced from Univest market data for the NSE listing. Only fields present in the source for this session are shown.

Price Action and Trading Activity

Trading on NSE opened at Rs 101.25, already close to the ceiling and far above the previous close of Rs 96.5. That opening level was also the low of the day, while the high of Rs 101.3 is the band price, so the whole session is a narrow sliver right at the top.

The gain over the previous close is Rs 4.8, or 4.97%. Once the price touched Rs 101.3 the exchange allowed no higher trade for the day. Every number here comes from NSE, since another exchange could carry a different band and previous close, and Rs 101.3 is the limit for this venue alone.

Why Sotac Pharmaceuticals Ltd. Hit Upper Circuit

Demand for Sotac Pharmaceuticals Ltd. ran up against the top of its exchange band, and the upper circuit fixed the price at Rs 101.3. The day offered no company announcement and no verified outside catalyst, so the move can only be read through price action and sentiment, and no stronger claim is made.

Results, corporate actions, sector news and rumours are left out of the explanation, as none is confirmed. Any announcement confirmed afterwards would be dealt with in an update of its own.

The upper circuit level in the session was Rs 101.3.

What the Sotac Pharmaceuticals Upper Circuit Means

Put simply, the upper circuit is the highest price the band lets Sotac Pharmaceuticals Ltd. reach in a single session, and on 28 October 2026 that was Rs 101.3. It caps movement and does not set a target for the price.

A band is meant to damp sharp swings and keep trading orderly. It records the session that has happened and forecasts no return, and because the next session begins with a limit worked out afresh, today's ceiling is not carried forward.

Sotac Pharmaceuticals Ltd. Fundamentals and Valuation

The reported figures add background to the price move. For Sotac Pharmaceuticals Ltd. the record lists book value of Rs 53.28, EPS of 5.22, a PE ratio of 18.49, a PB ratio of 1.81 and a market cap of Rs 106.63 crore. None of it is a buy, sell or hold view.

The price stands at nearly twice the book value of Rs 53.28 a share, which is what the PB ratio of 1.81 expresses, and the PE ratio of 18.49 is built on EPS of 5.22. A premium to book may reflect hopes of growth, the quality of assets or thin trading in a smaller counter, and the ratios alone cannot say which. The company is in healthcare, in pharmaceuticals and drugs, and no peer comparison is drawn.

A rise to the band catches attention, yet valuation, returns and the balance sheet each need a review of their own before a view of the business is formed.

Peer and Sector Context

Sotac Pharmaceuticals Ltd. belongs to the Pharmaceuticals & Drugs industry within the Healthcare sector. The peer table below uses available companies from the same sector or industry to give broader valuation context.

Peer Company	Market Cap	PE	PB	ROE
Advanced Enzyme Technologies Ltd.	Rs 2905.78 crore	17.52	1.75	11.43%
Hikal Ltd.	Rs 2494.37 crore	-	2.09	-3.97%
Fredun Pharmaceuticals Ltd.	Rs 2490.64 crore	56.84	8.17	16.09%
Dishman Carbogen Amcis Ltd.	Rs 2314.9 crore	143.25	0.35	1.56%
Beta Drugs Ltd.	Rs 2151.07 crore	41.43	4.91	18.78%

A dash in the PE column means no PE ratio was carried for that company in the source data, which happens when reported earnings are negative or have not been refreshed. Those companies are left out of the average below rather than counted as zero.

Several of these peers are far larger by market capitalisation than Sotac Pharmaceuticals Ltd. Size differences change liquidity and cost of capital, so the table is sector context rather than a like-for-like ranking.

Sotac Pharmaceuticals Ltd.'s PE ratio was 18.49, compared with an available peer PE average of 64.76, calculated from the 4 peer companies that had a PE on record. This comparison is a valuation reference point, not a recommendation.

Technical Snapshot

The technical snapshot adds context: RSI was 37.54.

Worth flagging: the RSI reading sits on the opposite side of neutral to the day move. Indicator values in the dataset can lag the live session, so they should be checked against a live chart before being relied on.

What Readers Should Know

The record confirms one narrow fact. On 28 October 2026 Sotac Pharmaceuticals Ltd. was locked at the NSE ceiling of Rs 101.3 after a gain of 4.97%.

At the band, buy orders gather while sellers stay away, so the quoted price may not be one at which an order fills, however clear the number on screen looks. Nothing official has been named as a catalyst for the rise.

This is a market update and no more. A price held at the limit leaves open the questions about the business, its valuation, liquidity, risk and any confirmed company disclosures, all of which need checks of their own.

Frequently Asked Questions

Why did Sotac Pharmaceuticals Ltd. hit upper circuit on 28 October 2026?

The stock reached its upper price band after buying interest during the session. No official company announcement or verified external catalyst was confirmed at the time of writing.

What was SOTAC share price on 28 October 2026?

The last traded price used in this article was Rs 101.3 on NSE. That price matched the upper circuit price captured for the event.

What was the upper circuit price for SOTAC?

The upper circuit price was Rs 101.3. The stated exchange upper circuit limit was Rs 101.3. The event numbers in this article are aligned to NSE.

What is Sotac Pharmaceuticals Ltd.'s market cap and PE ratio?

Sotac Pharmaceuticals Ltd.'s market cap was Rs 106.63 crore. PE ratio was 18.49.

Which exchange and data source were used?

The selected exchange was NSE. The article uses Univest market data available at the time of generation, captured on 28 October 2026.

Does hitting an upper circuit mean Sotac Pharmaceuticals Ltd. is a buy or a sell?

No. A circuit is an exchange price-band rule that caps how far a stock can move in a single session. It carries no view on valuation or business quality and is not a recommendation. Any decision should rest on fundamentals, valuation, liquidity and your own risk tolerance.

Can you buy or sell Sotac Pharmaceuticals Ltd. shares when the stock is at the upper circuit?

It is usually difficult. At the upper circuit, buy orders queue up while sellers step back, so there may be no counterparty at the quoted price. Orders can stay unfilled until the band opens up or sellers return.

What happens the next trading session after an upper circuit?

There is no fixed outcome. The band resets each session, so the stock can open freely, hit the same band again, or reverse. The exchange can also revise the applicable band width. The useful signals to watch are whether the company files any disclosure explaining the move.

What is the upper circuit limit set at for Indian stocks?

Exchange price bands are commonly set at 2%, 5%, 10% or 20% depending on the security, and the applicable band can be revised by the exchange. For Sotac Pharmaceuticals Ltd. the stated limit was Rs 101.3. For this session, Sotac Pharmaceuticals Ltd. moved 4.97%.